TECH Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

52.180

Open

51.610

VWAP

51.45

Vol

3.10M

Mkt Cap

8.05B

Low

50.678

Amount

159.41M

EV/EBITDA(TTM)

21.52

Total Shares

156.45M

8.14B

EV/OCF(TTM)

32.65

P/S(TTM)

6.65

Bio-Techne Corporation develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, advanced tissue-based in-situ hybridization assays and instrumentation for spatial genomic and tissue biopsy analysis and genetic and oncology kits for research and clinical applications. Its product portfolio and application enable scientific investigations into biological processes and molecular diagnostics and progression of specific diseases.

Events Timeline

(ET)

2026-02-16

13:50:00

Bio-Techne Launches Ella Platform CE-IVD Certification

2026-02-04 (ET)

2026-02-04

06:50:00

Bio-Techne Reports Q2 Revenue of $295.88M, Beating Expectations

2026-02-02 (ET)

2026-02-02

06:40:00

Bio-Techne Launches Cultrex Synthetic Hydrogel

News

6.5

03-13Fool

Hollow Brook Exits Entire Position in Bio-Techne

8.0

03-10NASDAQ.COM

Bio-Techne and UnitedHealth Options Trading Activity Surges

8.0

02-24NASDAQ.COM

Keysight and First Solar See Active Options Trading

4.5

02-23Barron's

S&P 500 Futures Decline in Pre-Market Session; International Paper and Smurfit Westrock Underperform

8.5

02-17NASDAQ.COM

Bio-Techne's Ella Platform Receives CE-IVD Marking for Clinical Use

8.5

02-16PRnewswire

Bio-Techne's Ella Platform Receives CE-IVD Certification

9 Analyst Rating

Wall Street analysts forecast TECH stock price to rise

6 Buy

3 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

60.00

Averages

66.14

High

72.00

Current: 0.000

Low

60.00

Averages

66.14

High

72.00

Baird

Neutral

maintain

$61 -> $70

AI Analysis

2026-02-05

Reason

Baird

Price Target

$61 -> $70

AI Analysis

2026-02-05

maintain

Neutral

Reason

Baird raised the firm's price target on Bio-Techne to $70 from $61 and keeps a Neutral rating on the shares. The firm updated its model following Q2 results and said they would be buyers of the shares on pullbacks.

UBS

Buy

maintain

$70 -> $79

2026-02-05

Reason

UBS

Price Target

$70 -> $79

2026-02-05

maintain

Buy

Reason

UBS raised the firm's price target on Bio-Techne to $79 from $70 and keeps a Buy rating on the shares.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for TECH

Unlock Now

Valuation Metrics

The current forward P/E ratio for Bio-Techne Corp (TECH.O) is 29.51, compared to its 5-year average forward P/E of 41.14. For a more detailed relative valuation and DCF analysis to assess Bio-Techne Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

41.14

Current PE

29.51

Overvalued PE

51.74

Undervalued PE

30.53

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

29.01

Current EV/EBITDA

21.79

Overvalued EV/EBITDA

35.88

Undervalued EV/EBITDA

22.14

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

10.87

Current PS

7.51

Overvalued PS

14.08

Undervalued PS

7.66

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

potential stocks to short

Intellectia · 8 candidates

Market Cap: >= 2.00BRegion: USQuarter Revenue Yoy Growth: <= 0.0%Pe Ttm: >= 30List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceBelowMA200Month Price Change Pct: <= $-10.00

Ticker

Name

Market Cap$

CARR

Carrier Global Corp

49.03B

Weyerhaeuser Co

16.74B

TTEK

Tetra Tech Inc

8.81B

TECH

Bio-Techne Corp

8.39B

GGAL

Grupo Financiero Galicia SA

7.30B

BBAR

Banco BBVA Argentina SA

3.08B

stocks likely to surge after market close

Intellectia · 5 candidates

Region: USMoving Average Relationship: PriceAboveMA5One Day Rise Prob: >= 60One Day Predict Return: >= 3.0%News Driver: Positive

Ticker

Name

Market Cap$

AEHR

Aehr Test Systems

1.20B

TECH

Bio-Techne Corp

8.57B

VRE

Veris Residential Inc

1.76B

SNPS

Synopsys Inc

80.61B

EBAY

eBay Inc

37.77B

so what Company is best for me

Intellectia · 79 candidates

Price: $5.00 - $400.00Relative Vol: >= 3List Exchange: XNYS, XNAS, XASEOne Week Rise Prob: >= 65One Week Predict Return: >= 5.0%Monthly Average Dollar Volume: >= 1,000,000

Ticker

Name

Market Cap$

ITGR

Integer Holdings Corp

3.00B

VERX

Vertex Inc

2.12B

SCHW

Charles Schwab Corp

164.81B

SPHR

Sphere Entertainment Co

3.95B

IRON

Disc Medicine Inc

2.42B

CRI

Carter's Inc

1.55B

stocks that predict to rise in one week

Intellectia · 39 candidates

Market Cap: >= 5.00BPrice: $10.00 - $250.00One Week Rise Prob: >= 72One Week Predict Return: >= 3.0%Monthly Average Dollar Volume: >= 1,000,000

Ticker

Name

Market Cap$

CVE

Cenovus Energy Inc

42.47B

SCHW

Charles Schwab Corp

164.81B

NiSource Inc

22.11B

ATO

Atmos Energy Corp

30.06B

CIGI

Colliers International Group Inc

5.69B

RGEN

Repligen Corp

7.62B

whats the next best swing trade

Intellectia · 70 candidates

Rsi Category: moderateMoving Average Relationship: PriceAboveMA20, PriceAboveMA200Month Price Change Pct: $8.00 - $25.00Is Index Component: GSPC, NDXMonthly Average Dollar Volume: >= 2,000,000

Ticker

Name

Market Cap$

CMI

Cummins Inc

78.93B

LRCX

Lam Research Corp

273.74B

Deere & Co

139.45B

PPG

PPG Industries Inc

25.20B

DXCM

Dexcom Inc

28.42B

MHK

Mohawk Industries Inc

7.46B

what stock should I buy this morning

Intellectia · 66 candidates

Price: $10.00 - $200.00List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA200Week Price Change Pct: $2.00 - $15.00Is Index Component: GSPC, DJI, NDXMonthly Average Dollar Volume: >= 1,000,000

Ticker

Name

Market Cap$

NEE

Nextera Energy Inc

174.63B

IEX

IDEX Corp

14.90B

HST

Host Hotels & Resorts Inc

12.85B

Ingersoll Rand Inc

35.49B

EXC

Exelon Corp

45.46B

TXT

Textron Inc

16.97B

find similar stocks of hims and hers

Intellectia · 208 candidates

Market Cap: 300.00M - 15.00BPs Ratio: <= 15.00Is Optionable: TrueAnnual Revenue Yoy Growth: >= 0.0%

Ticker

Name

Market Cap$

Guardant Health Inc

14.98B

ICLR

ICON PLC

14.12B

PEN

Penumbra Inc

14.03B

SOLV

Solventum Corp

13.94B

SNN

Smith & Nephew PLC

13.91B

NBIX

Neurocrine Biosciences Inc

13.50B

Whales Holding TECH

Ceredex Value Advisors LLC

Portolan Capital Management, LLC

Stephens Investment Management Group, LLC

Cramer Rosenthal McGlynn LLC

Grandeur Peak Global Advisors, LLC

Madison Investment Holdings, Inc

Trading Trends

People Also Watch

Frequently Asked Questions

What is Bio-Techne Corp (TECH) stock price today?

The current price of TECH is 51.48 USD — it has decreased -0.21

What is Bio-Techne Corp (TECH)'s business?

What is the price predicton of TECH Stock?

Wall Street analysts forecast TECH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TECH is66.14 USD with a low forecast of 60.00 USD and a high forecast of 72.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Bio-Techne Corp (TECH)'s revenue for the last quarter?

Bio-Techne Corp revenue for the last quarter amounts to 295.88M USD, decreased -0.39

What is Bio-Techne Corp (TECH)'s earnings per share (EPS) for the last quarter?

Bio-Techne Corp. EPS for the last quarter amounts to 0.24 USD, increased 9.09

How many employees does Bio-Techne Corp (TECH). have?

Bio-Techne Corp (TECH) has 3100 emplpoyees as of March 22 2026.

What is Bio-Techne Corp (TECH) market cap?

Today TECH has the market capitalization of 8.05B USD.

TECH Overview

TECH Overview

Events Timeline

News

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Related Community Screener

Whales Holding TECH

Trading Trends

People Also Watch

Frequently Asked Questions

What is Bio-Techne Corp (TECH) stock price today?

What is Bio-Techne Corp (TECH)'s business?

What is the price predicton of TECH Stock?

What is Bio-Techne Corp (TECH)'s revenue for the last quarter?

What is Bio-Techne Corp (TECH)'s earnings per share (EPS) for the last quarter?

How many employees does Bio-Techne Corp (TECH). have?

What is Bio-Techne Corp (TECH) market cap?